Psychiatry · Mobile, AL
NPI
1831145127
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7280 Sellers Ln
Mobile, AL, 36608
Phone (251) 450-2211
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,002
2,357 services
Medicare patients, 2024
88
Average age 60
Drug cost, 2024
$4.8M
10,234 prescriptions
Company payments, 2025
$2,239
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary E Cohen-Colson was code 96127 (behavioral health services), 64 times for 54 patients. In total Mary E Cohen-Colson billed 2,357 services in 13 codes, and Medicare paid $1,002.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96127 Behavioral Health Services | Office | 64 | 54 | $0.15 | $9.56 |
| 83036 Blood Count | Office | 39 | 35 | $9.52 | $371 |
| 80061 Clinical Chemistry | Office | 24 | 21 | $13.12 | $315 |
| 36415 Venipuncture Blood Collection | Office | 22 | 19 | $8.65 | $190 |
By year: 2022 $951 for 33 services; 2023 $1,225 for 3,253 services; 2024 $1,002 for 2,357 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 39 | 35 | $9.52 | $371 |
| 80061 Clinical Chemistry | 24 | 21 | $13.12 | $315 |
| 36415 Venipuncture Blood Collection | 22 | 19 | $8.65 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary E Cohen-Colson prescribed most often to Medicare patients was Benztropine Mesylate, with 864 prescriptions and refills. In total Mary E Cohen-Colson wrote 10,234 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Benztropine Mesylate Generic | 864 | 948 | 95 | $11K |
| Trazodone Hcl Generic | 635 | 741 | 84 | $4,410 |
| Clozapine Generic | 582 | 598 | 32 | $42K |
| Invega Sustenna Paliperidone Palmitate | 418 | 418 | 45 | $1.3M |
| Divalproex Sodium Er Divalproex Sodium | 380 | 421 | 44 | $14K |
| Olanzapine Generic | 334 | 363 | 38 | $5,587 |
| Quetiapine Fumarate Generic | 318 | 349 | 35 | $3,642 |
| Haloperidol Generic | 292 | 310 | 29 | $7,319 |
| Propranolol Hcl Generic | 289 | 317 | 32 | $3,436 |
| Buspirone Hcl Generic | 260 | 317 | 35 | $3,323 |
| Mirtazapine Generic | 247 | 282 | 30 | $2,940 |
| Risperidone Generic | 246 | 286 | 30 | $3,479 |
| Gabapentin Generic | 178 | 178 | 19 | $1,720 |
| Lorazepam Generic | 177 | 177 | 21 | $1,478 |
| Olanzapine Odt Olanzapine | 177 | 185 | 16 | $8,435 |
Brand drugs: 1,234 claims; generic drugs: 9,000 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary E Cohen-Colson $2,239 ($2,239 in general payments such as food, travel and fees) from 9 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $554.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 19 | $554 |
| Neurocrine BioSciences, Inc. NBIX | 18 | $509 |
| Alkermes, Inc. ALKS | 13 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $296 |
| E.R. Squibb & Sons, L.L.C. BMY | 25 | $279 |
| Vanda Pharmaceuticals Inc. VNDA | 13 | $175 |
| Lundbeck LLC | 4 | $74.29 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $23.85 |
| Axsome Therapeutics, Inc. AXSM | 1 | $23.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.